PharmacoEconomics

Letter From the Commissioner's Office at the US FDA
pp. 267-268(2)
Author: Vernon, John A.

Measuring Patient-Reported Outcomes in Solid Organ Transplant Recipients: An Overview of Instruments Developed to Date
pp. 269-286(18)
Authors: Cleemput, Irina; Dobbels, Fabienne

The Economic Implications of Glaucoma: A Literature Review
pp. 287-308(22)
Authors: Schmier, Jordana K.; Halpern, Michael T.; Jones, Mechelle L.

Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer
pp. 309-327(19)
Authors: Zeliadt, Steven B.; Penson, David F.

Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients: US Healthcare System Perspective
pp. 329-342(14)
Authors: Delea, Thomas E.; Sofrygin, Oleg; Thomas, Simu K.; Baladi, Jean-Francois; Phatak, Pradyumna D.; Coates, Thomas D.

Therapeutic Use of Granulocyte Colony-Stimulating Factors for Established Febrile Neutropenia: Effect on Costs from a Hospital Perspective
pp. 343-351(9)
Authors: Cosler, Leon E.; Eldar-Lissai, Adi; Culakova, Eva; Kuderer, Nicole M.; Dale, David; Crawford, Jeffrey; Lyman, Gary H.

Book Review
pp. 353-353(1)
Author: Adis International Limited,